var data={"title":"Etomidate: Pediatric drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Etomidate: Pediatric drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/6167?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=etomidate-drug-information\" class=\"drug drug_general\">see &quot;Etomidate: Drug information&quot;</a> and <a href=\"topic.htm?path=etomidate-patient-drug-information\" class=\"drug drug_patient\">see &quot;Etomidate: Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F169136\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Amidate</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1058557\" class=\"list_set htclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Therapeutic Category</span>\n    <ul>\n      <li>\n        <span class=\"list-set-name\">General Anesthetic</span></li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1058552\" class=\"block dos drugH1Div\"><span class=\"drugH1\">Dosing: Usual</span><p>(For additional information <a href=\"topic.htm?path=etomidate-drug-information\" class=\"drug drug_general\">see &quot;Etomidate: Drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Pediatric:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Anesthesia, induction:</b></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Infants: Very limited data available: IV: 0.2 to 0.3 mg/kg/dose as a single dose; dosing based on a prospective, observational trial and two pharmacokinetic studies (Kay 1976; Lin 2012; Su 2015)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Children &lt;10 years: Limited data available: IV: 0.2 to 0.3 mg/kg/dose as a single dose (Cot&eacute; 2013; Du 2015; Kay 1976)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Children &ge;10 years and Adolescents: Usual dose: IV: 0.3 mg/kg/dose as a single dose; range: 0.2 to 0.6 mg/kg/dose</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Procedural sedation: </b>Limited data available; dosing variable: Infants &ge;6 months, Children, and Adolescents: IV: Usual initial dose: 0.2 mg/kg/dose prior to procedure (reported range: 0.1 to 0.4 mg/kg/dose); repeat doses may be needed depending on patient response and duration of the procedure; repeat doses vary in the literature and range from 0.1 to 0.2 mg/kg/dose; reported total dose ranged from 0.3 to 0.6 mg/kg/procedure; dosing based on several prospective and retrospective studies primarily in the ED setting; procedures included orthopedic reductions and sedation for CT scans (Baxter 2007; Dickinson 2001; Di Liddo 2006; Lee-Jayaram 2010; Kienstra 2004; Mandt 2012). <b>Note</b>: Etomidate does <b>not</b> have analgesic properties; additional therapy (eg, fentanyl) may be needed for painful procedures (ACEP [Godwin 2014]).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Rapid sequence intubation (RSI):</b> Limited data available: Infants, Children, and Adolescents: IV, Intraosseous: 0.2 to 0.4 mg/kg/dose as a single dose; maximum dose: 20 mg/dose (AHA [Hazinski 2015]; Hegenbarth 2008). <b>Note:</b> Not recommended for patients in septic shock due to an association between transient adrenocortical suppression and increased mortality rate (den Brinker 2008; PALS [Kleinman 2010]).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Adult:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>General anesthesia: </b>IV: Initial: 0.3 mg/kg/dose (range: 0.2 to 0.6 mg/kg/dose) over 30 to 60 seconds for induction of anesthesia</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Supplementation to subpotent anesthetic agents:</b> IV: Administer smaller increments during short operative procedures to supplement subpotent anesthetic agents, such as nitrous oxide; individualize dosage (usually smaller than the original induction dose)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F169120\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Intravenous: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Amidate: 2 mg/mL (10 mL, 20 mL) [contains propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 2 mg/mL (10 mL, 20 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Intravenous [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 2 mg/mL (10 mL, 20 mL)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F169106\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Availability (US)</span>\n    <p style=\"text-indent:0em;display:inline\">Yes</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1058560\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">IV: Administer IV push over 30 to 60 seconds; very irritating; avoid administration into small vessels on the head or dorsum of the hand (Kay 1976); preadministration of lidocaine may be beneficial (Baxter 2007; Lee-Jayaram 2010)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F169134\" class=\"block sts drugH1Div\"><span class=\"drugH1\">Storage/Stability</span>\n    <p style=\"text-indent:0em;display:inline\">Store at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1058559\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">Induction of general anesthesia (FDA approved in ages &ge;10 years and adults); supplementation of subpotent anesthetic agents during maintenance of general anesthesia for short operative procedures (FDA approved in adults); has also been used for procedural sedation and rapid sequence intubation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F169171\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues: </span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Etomidate may be confused with etidronate</p></div>\r\n</div>\r\n\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">High alert medication:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error. </p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F169168\" class=\"block arm drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Central nervous system: Myoclonus</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Endocrine &amp; metabolic: Adrenal suppression</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gastrointestinal: Hiccups, nausea, vomiting (on emergence from anesthesia)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Local: Pain at injection site</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Neuromuscular &amp; skeletal: Musculoskeletal disease (transient skeletal movements)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Ophthalmic: Nystagmus</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Rare but important or life-threatening: Apnea, bradycardia, cardiac arrhythmia, decreased cortisol (decreased cortisol synthesis), hypertension, hyperventilation, hypotension, hypoventilation, laryngospasm, muscle spasm (masseter; Bozeman 2002), tachycardia</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F169124\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Hypersensitivity to etomidate or any component of the formulation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F169110\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Adrenal steroid production: Etomidate inhibits 11-B-hydroxylase, an enzyme important in adrenal steroid production. A single induction dose blocks the normal stress-induced increase in adrenal cortisol production for 6 to 8 hours, up to 24 hours in elderly and debilitated patients. Continuous infusion of etomidate for sedation in the ICU may increase mortality because patients may not be able to respond to stress. Administration by continuous infusion is not recommended by the manufacturer. No increase in mortality has been identified with a single dose for induction of anesthesia (McPhee 2013).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Heart failure: In a scientific statement from the American Heart Association, etomidate has been determined to be an agent that may exacerbate underlying myocardial dysfunction (magnitude: moderate) (AHA [Page 2016]).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Renal impairment: Risk of toxicity is greater in patients with renal impairment; use with caution and monitor renal function.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Special populations:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Elderly: May induce cardiac depression in elderly patients, especially those with hypertension; may require lower doses.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Pediatric neurotoxicity: In pediatric and neonatal patients &lt;3 years and patients in third trimester of pregnancy (ie, times of rapid brain growth and synaptogenesis), the repeated or lengthy exposure to sedatives or anesthetics during surgery/procedures may have detrimental effects on child or fetal brain development and may contribute to various cognitive and behavioral problems. Epidemiological studies in humans have reported various cognitive and behavioral problems, including neurodevelopmental delay (and related diagnoses), learning disabilities, and ADHD. Human clinical data suggest that single, relatively short exposures are not likely to have similar negative effects. No specific anesthetic/sedative has been found to be safer. For elective procedures, risks versus benefits should be evaluated and discussed with parents/caregivers/patients; critical surgeries should not be delayed (FDA 2016).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: When considering use, weigh etomidate hemodynamic properties against the high frequency of transient skeletal muscle movements.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Experienced personnel: According to the manufacturer, etomidate should only be administered by experienced personnel trained in the administration of general anesthetics and in the management of complications encountered during the conduct of general anesthesia. Consult local regulations and individual institutional policies and procedures.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F26535332\" class=\"block add-pediatric-warn-info drugH1Div\"><span class=\"drugH1\">Warnings: Additional Pediatric Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Adrenal suppression has been documented with etomidate use, even after a single dose. Cortisol concentrations decrease quickly after the induction dose, lasting up to 8 hours in healthy adults and up to 24 hours in pediatric surgical patients; however, 2 prospective pediatric studies have reported no adverse clinical outcomes due to the adrenal suppression (Du 2015; Gu 2015). However, a retrospective study of pediatric patients admitted for meningococcal sepsis found patients receiving a single etomidate dose for rapid sequence intubation (n=23) had significantly decreased cortisol concentrations for at least 24 hours, and higher ACTH and 11-deoxycortisol concentrations compared to those who did not receive etomidate. In this study, 8 patients died due to hemodynamic failure, 7 of whom had received etomidate. While the role of etomidate on mortality is unclear in these cases, weigh the risk versus benefit prior to use and if use deemed necessary use with caution (den Brinker 2008). Etomidate use is not recommended in pediatric patients with sepsis or septic shock (Brierley 2009; Dellinger 2013; PALS [Kleinman 2010]).</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">In pediatric and neonatal patients &lt;3 years of age and patients in third trimester of pregnancy (ie, times of rapid brain growth and synaptogenesis), the repeated or lengthy exposure to sedatives or anesthetics during surgery/procedures may have detrimental effects on the child's or fetus&rsquo; brain development and may contribute to various cognitive and behavioral problems; the FDA is requiring warnings be included in the manufacturer's labeling for all general anesthetic/sedative drugs. Multiple animal species studies have shown adverse effects on brain maturation; in juvenile animals, drugs that potentiate GABA activity and/or block NMDA receptors for &gt;3 hours demonstrated widespread neuronal and oligodendrocyte cell loss along with alteration in synaptic morphology and neurogenesis. Epidemiological studies in humans have reported various cognitive and behavioral problems including neurodevelopmental delay (and related diagnoses), learning disabilities, and ADHD. Human clinical data suggest that single, relatively short exposures are not likely to have similar negative effects. Further studies are needed to fully characterize findings and ensure that these findings are not related to underlying conditions or the procedure itself. No specific anesthetic/sedative has been found to be safer. For elective procedures, risk vs benefits should be evaluated and discussed with parents/caregivers/patients; critical surgeries should not be delayed (FDA 2016).</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures, and respiratory depression; use caution (AAP 1997; Shehab 2009).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13299304\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F169115\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=12907&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Benznidazole: May enhance the adverse/toxic effect of Products Containing Propylene Glycol.<i> Risk X: Avoid combination</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13763473\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Adverse events have been observed in animal reproduction studies. Based on animal data, repeated or prolonged use of general anesthetic and sedation medications that block N-methyl-D- aspartate receptors and/or potentiate GABA activity may affect brain development. Human fetuses may be most vulnerable during the third trimester. Until additional information is available, the benefits and risks of maternal treatment with etomidate during pregnancy should be evaluated, especially for procedures lasting more than 3 hours. The ACOG recommends that pregnant women should not be denied medically indicated surgery or procedures, regardless of trimester. If the procedure is elective, it should be delayed until after delivery (ACOG 2011).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1058556\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Cardiac monitoring, blood pressure, respiratory rate, renal function, level of sedation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F169109\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Ultra-short-acting nonbarbiturate general anesthetic (benzylimidazole) used for rapid induction of anesthesia with minimal cardiovascular effects; produces EEG burst suppression at high doses.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F169123\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics (Adult data unless noted)</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Onset of action: 30 to 60 seconds</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Peak effect: 1 minute</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Duration: Dose dependent: 2 to 3 minutes (0.15 mg/kg dose); 3 to 5 minutes (0.3 mg/kg dose); rapid recovery is due to rapid redistribution</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Distribution: V<sub>d</sub>: 2 to 4.5 L/kg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Protein binding: 76%; decreased protein binding resulting in an increased percentage of &ldquo;free&rdquo; etomidate in patients with renal failure or hepatic cirrhosis</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Metabolism: Hepatic and plasma esterases</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Half-life elimination: Terminal: 2.6 to 3.5 hours</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Time to peak, serum: 7 minutes</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Excretion: Urine ~75% (80% as metabolite; 2% as unchanged drug)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16323138\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Amidate Intravenous)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2 mg/mL (20 mL): $7.67</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Etomidate Intravenous)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2 mg/mL (10 mL): $7.78</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F169126\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Endata (CO);</li>\n      <li>Etomid (BD);</li>\n      <li>Etomidat-Lipuro (CH, LU);</li>\n      <li>Etomidato-Lipuro (AR);</li>\n      <li>Hypnomidate (AT, BE, BG, BR, CH, CZ, DE, ES, FR, GB, GR, HR, LU, MT, MX, NL, PL, PT, PY, RU, SI, TR, TW, ZA, ZW)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    ACOG Committee on Obstetric Practice. ACOG Committee Opinion No. 474: nonobstetric surgery during pregnancy. <i>Obstet Gynecol</i>. 2011;117(2, pt 1):420-421. doi:10.1097/AOG.0b013e31820eede9.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/21252774/pubmed\" target=\"_blank\" id=\"21252774\">21252774</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    American Academy of Pediatrics Committee on Drugs. &quot;Inactive&quot; ingredients in pharmaceutical products: update (subject review). <i>Pediatrics</i>. 1997;99(2):268-278.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/9024461/pubmed\" target=\"_blank\" id=\"9024461\">9024461</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Amidate injection (etomidate) [prescribing information]. Lake Forest, IL: Hospira, Inc; May 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Baxter AL, Mallory MD, Spandorfer PR, et al. Etomidate versus pentobarbital for computed tomography sedations: report from the Pediatric Sedation Research Consortium. <i>Pediatr Emerg Care</i>. 2007;23(10):690-695.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/18090099/pubmed\" target=\"_blank\" id=\"18090099\">18090099</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Bozeman WP, Young S. Etomidate as a sole agent for endotracheal intubation in the prehospital air medical setting. <i>Air Med J</i>. 2002;21(4):32-55.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/12087322/pubmed\" target=\"_blank\" id=\"12087322\">12087322</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Brierley J, Carcillo JA, Choong K, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. <i>Crit Care Med</i>. 2009;37(2):666-688.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/19325359/pubmed\" target=\"_blank\" id=\"19325359\">19325359</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cot&eacute; CJ, Lerman J, Anderson B, eds. <i>A Practice of Anesthesia for Infants and Children</i>. 5th ed. Philadelphia, PA: Saunders Elsevier; 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. <i>Intensive Care Med</i>. 2013;39(2):165-228.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/23361625/pubmed\" target=\"_blank\" id=\"23361625\">23361625</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    den Brinker M, Hokken-Koelega AC, Hazelzet JA, de Jong FH, Hop WC, Joosten KF. One single dose of etomidate negatively influences adrenocortical performance for at least 24h in children with meningococcal sepsis. <i>Intensive Care Med</i>. 2008;34(1):163-168.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/17710382/pubmed\" target=\"_blank\" id=\"17710382\">17710382</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Dickinson R, Singer AJ, Carrion W. Etomidate for pediatric sedation prior to fracture reduction. <i>Acad Emerg Med</i>. 2001;8(1):74-77.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/11136155/pubmed\" target=\"_blank\" id=\"11136155\">11136155</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Di Liddo L, D'Angelo A, Nguyen B, Bailey B, Amre D, Stanciu C. Etomidate versus midazolam for procedural sedation in pediatric outpatients: a randomized controlled trial. <i>Ann Emerg Med</i>. 2006;48(4):433-440, 440.e1.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/16997680/pubmed\" target=\"_blank\" id=\"16997680\">16997680</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Du Y, Chen YJ, He B, Wang YW. The Effects of Single-Dose Etomidate Versus Propofol on Cortisol Levels in Pediatric Patients Undergoing Urologic Surgery: A Randomized Controlled Trial. <i>Anesth Analg</i>. 2015;121(6):1580-1585.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/26496368/pubmed\" target=\"_blank\" id=\"26496368\">26496368</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Falk J and Zed PJ, &ldquo;Etomidate for Procedural Sedation in the Emergency Department,&rdquo; <i>Ann Pharmacother</i>, 2004, 38(7-8):1272-7.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/15173551/pubmed\" target=\"_blank\" id=\"15173551\">15173551</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Godwin SA, Burton JH, Gerardo CJ, Hatten BW, Mace SE, Silvers SM, Fesmire FM; American College of Emergency Physicians. Clinical policy: procedural sedation and analgesia in the emergency department. <i>Ann Emerg Med</i>. 2014;63(2):247-58.e18.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/24438649/pubmed\" target=\"_blank\" id=\"24438649\">24438649</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Gu H, Zhang M, Cai M, Liu J. Comparison of Adrenal Suppression between Etomidate and Dexmedetomidine in Children with Congenital Heart Disease. <i>Med Sci Monit</i>. 2015;21:1569-1576.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/26022508/pubmed\" target=\"_blank\" id=\"26022508\">26022508</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hazinski MF, Shuster M, Donnino MW, et al.<i> 2015 Handbook of Emergency Cardiovascular Care for Healthcare Providers</i>. South Deerfield, MA: American Heart Association; 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hegenbarth MA, American Academy of Pediatrics Committee on Drugs. Preparing for pediatric emergencies: drugs to consider. <i>Pediatrics</i>. 2008;121(2):433-443.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/18245435/pubmed\" target=\"_blank\" id=\"18245435\">18245435</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kay B. A clinical assessment of the use of etomidate in children. <i>Br J Anaesth</i>. 1976;48(3):207-211.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/1259886/pubmed\" target=\"_blank\" id=\"1259886\">1259886</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kienstra AJ, Ward MA, Sasan F, et al, &ldquo;Etomidate Versus Pentobarbital for Sedation of Children for Head and Neck CT Imaging,&rdquo; <i>Pediatr Emerg Care</i>, 2004, 20(8):499-506.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/15295244/pubmed\" target=\"_blank\" id=\"15295244\">15295244</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kleinman ME, Chameides L, Schexnayder SM, et al. Part 14: pediatric advanced life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. <i>Circulation</i>. 2010;122(18 Suppl 3):S876-908.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/20956230/pubmed\" target=\"_blank\" id=\"20956230\">20956230</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lee-Jayaram JJ, Green A, Siembieda J, et al. Ketamine/midazolam versus etomidate/fentanyl: procedural sedation for pediatric orthopedic reductions. <i>Pediatr Emerg Care</i>. 2010;26(6):408-412.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/20502386/pubmed\" target=\"_blank\" id=\"20502386\">20502386</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lin L, Zhang JW, Huang Y, Bai J, Cai MH, Zhang MZ. Population pharmacokinetics of intravenous bolus etomidate in children over 6 months of age. <i>Paediatr Anaesth</i>. 2012;22(4):318-326.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/21917057/pubmed\" target=\"_blank\" id=\"21917057\">21917057</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Mandt MJ, Roback MG, Bajaj L, Galinkin JL, Gao D, Wathen JE. Etomidate for short pediatric procedures in the emergency department. <i>Pediatr Emerg Care</i>. 2012;28(9):898-904.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/22929142/pubmed\" target=\"_blank\" id=\"22929142\">22929142</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    McPhee LC, Badawi O, Fraser GL, et al. Single-dose etomidate is not associated with increased mortality in ICU patients with sepsis: analysis of a large electronic ICU database. <i>Crit Care Med</i>. 2013;41(3):774-783.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/23318491/pubmed\" target=\"_blank\" id=\"23318491\">23318491</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Page RL 2nd, O'Bryant CL, Cheng D, et al; American Heart Association Clinical Pharmacology and Heart Failure and Transplantation Committees of the Council on Clinical Cardiology; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular and Stroke Nursing; and Council on Quality of Care and Outcomes Research. Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement From the American Heart Association [published correction appears in <i>Circulation</i>. 2016;134(12):e261]. <i>Circulation</i>. 2016;134(6):e32-e69.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/27400984/pubmed\" target=\"_blank\" id=\"27400984\">27400984</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/19188870/pubmed\" target=\"_blank\" id=\"19188870\">19188870</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Su F, El-Komy MH, Hammer GB, Frymoyer A, Cohane CA, Drover DR. Population pharmacokinetics of etomidate in neonates and infants with congenital heart disease. <i>Biopharm Drug Dispos</i>. 2015;36(2):104-114.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/25377074/pubmed\" target=\"_blank\" id=\"25377074\">25377074</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tobias JD, &ldquo;Etomidate: Applications in Pediatric Critical Care and Pediatric Anesthesiology,&rdquo; <i>Pediatr Crit Care Med</i>, 2000, 1(2):100-6.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/etomidate-pediatric-drug-information/abstract-text/12813258/pubmed\" target=\"_blank\" id=\"12813258\">12813258</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    US Food and Drug Administration. FDA Drug Safety Communication: FDA review results in new warnings about using general anesthetics and sedation drugs in young children and pregnant women. Available at <a href=\"https://www.fda.gov/Drugs/DrugSafety/ucm532356.htm\" target=\"_blank\">https://www.fda.gov/Drugs/DrugSafety/ucm532356.htm</a>. Updated December 14, 2016. Accessed May 26, 2017.</div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 12907 Version 121.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F169136\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Therapeutic Category\" href=\"#F1058557\" class=\"outlineLink\">Therapeutic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Usual\" href=\"#F1058552\" class=\"outlineLink\">Dosing: Usual</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F169120\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Availability (US)\" href=\"#F169106\" class=\"outlineLink\">Generic Availability (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F1058560\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Storage/Stability\" href=\"#F169134\" class=\"outlineLink\">Storage/Stability</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F1058559\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F169171\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F169168\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F169124\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F169110\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Warnings: Additional Pediatric Considerations\" href=\"#F26535332\" class=\"outlineLink\">Warnings: Additional Pediatric Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13299304\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F169115\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F13763473\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F1058556\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F169109\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics (Adult data unless noted)\" href=\"#F169123\" class=\"outlineLink\">Pharmacodynamics/Kinetics (Adult data unless noted)</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F16323138\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F169126\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_PED/12907|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=etomidate-drug-information\" class=\"drug drug_general\">Etomidate: Drug information</a></li><li><a href=\"topic.htm?path=etomidate-patient-drug-information\" class=\"drug drug_patient\">Etomidate: Patient drug information</a></li></ul></div></div>","javascript":null}